Kong Yu-Gyeong, Kim Ji Yoon, Yu Jihion, Lim Jinwook, Hwang Jai-Hyun, Kim Young-Kug
From the Department of Anesthesiology and Pain Medicine, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Republic of Korea.
Medicine (Baltimore). 2016 May;95(19):e3685. doi: 10.1097/MD.0000000000003685.
Radical cystectomy, which is performed to treat muscle-invasive bladder tumors, is among the most difficult urological surgical procedures and puts patients at risk of intraoperative blood loss and transfusion. Fluid management via stroke volume variation (SVV) is associated with reduced intraoperative blood loss. Therefore, we evaluated the efficacy and safety of SVV-guided fluid therapy for reducing blood loss and transfusion requirements in patients undergoing radical cystectomy.This study included 48 patients who underwent radical cystectomy, and these patients were randomly allocated to the control group and maintained at <10% SVV (n = 24) or allocated to the trial group and maintained at 10% to 20% SVV (n = 24). The primary endpoints were comparisons of the amounts of intraoperative blood loss and transfused red blood cells (RBCs) between the control and trial groups during radical cystectomy. Intraoperative blood loss was evaluated through the estimated blood loss and estimated red cell mass loss. The secondary endpoints were comparisons of the postoperative outcomes between groups.A total of 46 patients were included in the final analysis: 23 patients in the control group and 23 patients in the trial group. The SVV values in the trial group were significantly higher than in the control group. Estimated blood loss, estimated red cell mass loss, and RBC transfusion requirements in the trial group were significantly lower than in the control group (734.3 ± 321.5 mL vs 1096.5 ± 623.9 mL, P = 0.019; 274.1 ± 207.8 mL vs 553.1 ± 298.7 mL, P <0.001; 0.5 ± 0.8 units vs 1.9 ± 2.2 units, P = 0.005). There were no significant differences in postoperative outcomes between the two groups.SVV-guided fluid therapy (SVV maintained at 10%-20%) can reduce blood loss and transfusion requirements in patients undergoing radical cystectomy without resulting in adverse outcomes. These findings provide useful information for optimal fluid management during radical cystectomy.
根治性膀胱切除术用于治疗肌层浸润性膀胱肿瘤,是泌尿外科最具挑战性的手术之一,术中患者有失血和输血风险。通过每搏量变异度(SVV)进行液体管理可减少术中失血。因此,我们评估了SVV指导下的液体治疗对减少根治性膀胱切除术患者失血及输血需求的有效性和安全性。本研究纳入48例行根治性膀胱切除术的患者,随机分为对照组,维持SVV<10%(n = 24),或试验组,维持SVV在10%至20%(n = 24)。主要终点是比较对照组和试验组在根治性膀胱切除术中的术中失血量和输注红细胞量。术中失血通过估计失血量和估计红细胞量损失进行评估。次要终点是比较两组术后结局。最终分析共纳入46例患者:对照组23例,试验组23例。试验组的SVV值显著高于对照组。试验组的估计失血量、估计红细胞量损失和红细胞输血需求量显著低于对照组(734.3±321.5 mL对1096.5±623.9 mL,P = 0.019;274.1±207.8 mL对553.1±298.7 mL,P<0.001;0.5±0.8单位对`1.9±2.2单位,P = 0.005)。两组术后结局无显著差异。SVV指导下的液体治疗(SVV维持在10%-20%)可减少根治性膀胱切除术患者的失血和输血需求,且无不良后果。这些发现为根治性膀胱切除术期间的最佳液体管理提供了有用信息。